Jounce Therapeutics (JNCE) PT Raised to $35 at Baird
Tweet Send to a Friend
Baird analyst Michael Ulz raised his price target on Jounce Therapeutics (NASDAQ: JNCE) to $35.00 (from $30.00) while maintaining aanOutperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
